Jul 23, 2014 at 13:00 | Source: Moneycontrol.com
Mid and small caps underperform the benchmark indices. IT stocks support the upmove. Infosys, Hindalco, TCS, Wipro and ICICI Bank are top gainers in the Sensex. Among the losers are Tata Steel, Axis Bank, Tata Power, Tata Motors and Sun Pharma.
Jul 23, 2014 at 12:47 | Source: CNBC-TV18
Telecom Regulatory Authority of India (TRAI) has recommended renewal of DTH licence by 10 years to 20 years and has proposed one-time entry fee of Rs 10 crore for new DTH licenses. It has said that the cross-holding policy for DTH players will be restructured with an aim that one broadcaster will control Only one DTH or cable company.
Jul 23, 2014 at 12:11 | Source: Moneycontrol.com
Attorney-General Mukul Rohtagi has said that there was enough evidence with the agency to file charge sheet against former Telecom Minister Dayanidhi Maran and his brother Kalanithi in the Aircel-Maxis deal case.
Jul 23, 2014 at 11:55 | Source: CNBC-TV18
Here are a few top buzzing stocks picked by CNBC-TV18's analysts in trade today KPIT Technologies, Max India, Ceat, Sun TV, ING Vysya and Strides Arcolab.
Jul 14, 2014 at 14:47 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com recommends buying Hero Motocorp and advises selling Sun TV and NTPC.
Jul 14, 2014 at 12:18 | Source: CNBC-TV18
Here are a few of the movers and shakers of the day which CNBC-TV18's analysts have picked - Sun Pharma, Sanofi India, OBC, State Bank of Travancore, Syndicate Bank, Infosys, Advani Hotels, Delta Corp, Suzlon and DCB.
Jul 12, 2014 at 15:39 | Source: CNBC-TV18
In an interview to CNBC-TV18's Sonia Shenoy and Anuj Singhal, Vibhav Kapoor of IL&FS spoke about the market and their outlook for next week's trade.
Jul 02, 2014 at 10:35 | Source: CNBC-TV18
SL Narayanan, Group CFO, Sun Group, discusses about his expectations from the Union Budget for media sector.
Jun 30, 2014 at 14:00 | Source: CNBC-TV18
According to Uday Baldota of Sun Pharma winning CNBC-TV18's CFO award in the pharma and healthcare space is recognition of the company's good performance.
Jun 27, 2014 at 08:25 | Source: CNBC-TV18
Vishal Kshatriya of Edelweiss advises buying UPL with a target of Rs 350 and Biocon with a target of Rs 550.